These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

359 related items for PubMed ID: 9466562

  • 1. Abnormal accumulation of NACP/alpha-synuclein in neurodegenerative disorders.
    Takeda A, Mallory M, Sundsmo M, Honer W, Hansen L, Masliah E.
    Am J Pathol; 1998 Feb; 152(2):367-72. PubMed ID: 9466562
    [Abstract] [Full Text] [Related]

  • 2. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
    Takeda A, Hashimoto M, Mallory M, Sundsumo M, Hansen L, Sisk A, Masliah E.
    Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
    [Abstract] [Full Text] [Related]

  • 3. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.
    Wakabayashi K, Matsumoto K, Takayama K, Yoshimoto M, Takahashi H.
    Neurosci Lett; 1997 Dec 12; 239(1):45-8. PubMed ID: 9547168
    [Abstract] [Full Text] [Related]

  • 4. Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies.
    Arima K, Hirai S, Sunohara N, Aoto K, Izumiyama Y, Uéda K, Ikeda K, Kawai M.
    Brain Res; 1999 Oct 02; 843(1-2):53-61. PubMed ID: 10528110
    [Abstract] [Full Text] [Related]

  • 5. NACP/alpha-synuclein immunoreactivity in diffuse neurofibrillary tangles with calcification (DNTC).
    Yokota O, Terada S, Ishizu H, Tsuchiya K, Kitamura Y, Ikeda K, Uéda K, Kuroda S.
    Acta Neuropathol; 2002 Oct 02; 104(4):333-41. PubMed ID: 12200618
    [Abstract] [Full Text] [Related]

  • 6. Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease.
    Masliah E, Iwai A, Mallory M, Uéda K, Saitoh T.
    Am J Pathol; 1996 Jan 02; 148(1):201-10. PubMed ID: 8546207
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Non-Abeta component of Alzheimer's disease amyloid (NAC) revisited. NAC and alpha-synuclein are not associated with Abeta amyloid.
    Culvenor JG, McLean CA, Cutt S, Campbell BC, Maher F, Jäkälä P, Hartmann T, Beyreuther K, Masters CL, Li QX.
    Am J Pathol; 1999 Oct 02; 155(4):1173-81. PubMed ID: 10514400
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple system atrophy.
    Wakabayashi K, Hayashi S, Kakita A, Yamada M, Toyoshima Y, Yoshimoto M, Takahashi H.
    Acta Neuropathol; 1998 Nov 02; 96(5):445-52. PubMed ID: 9829807
    [Abstract] [Full Text] [Related]

  • 11. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity.
    Irizarry MC, Growdon W, Gomez-Isla T, Newell K, George JM, Clayton DF, Hyman BT.
    J Neuropathol Exp Neurol; 1998 Apr 02; 57(4):334-7. PubMed ID: 9600226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. NACP/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains.
    Wakabayashi K, Hayashi S, Yoshimoto M, Kudo H, Takahashi H.
    Acta Neuropathol; 2000 Jan 02; 99(1):14-20. PubMed ID: 10651022
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lewy body in neurodegeneration with brain iron accumulation type 1 is immunoreactive for alpha-synuclein.
    Arawaka S, Saito Y, Murayama S, Mori H.
    Neurology; 1998 Sep 02; 51(3):887-9. PubMed ID: 9748051
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.